Merck (MRK) EVP Richard R. DeLuca Sells 37,685 Shares

What Happened
Richard R. DeLuca, Executive Vice President and President of Merck Animal Health, sold 37,685 Merck (MRK) shares in an open-market transaction on February 6, 2026. The weighted average sale price reported was $120.92 per share, for a total proceeds of $4,557,025. This was a sale (not a purchase or option exercise).

Key Details

• Transaction date: 2026-02-06
• Reported price: weighted average $120.92 per share (range: $120.7350 to $121.3054 per footnote)
• Shares sold: 37,685
• Total proceeds: $4,557,025 (≈ $4.56M)
• Shares owned after the transaction: not specified in the provided filing
• Footnote: price is a weighted average from multiple trades; the filer can provide the breakdown of individual trade prices on request (Footnote F1)
• Timeliness: filing shows the same report date (2026-02-06); no late-filing flag noted

Context
This filing documents an outright sale of common stock by a senior executive. Sales by insiders are often routine (e.g., for diversification or liquidity) and the filing does not state a reason, so it should not be taken alone as an indicator of company outlook. No option exercises, awards, gifts, or 10b5-1 plan references were reported in this transaction.